Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01607229 · ClinicalTrials.gov registry record
Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 25
- Enrollment target
NCT01607229: Completed study, sponsored by University of Southern California.
NCT01607229 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01607229 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
SPECIFIC AIM: Determine the validity of the Biospace bioelectrical impedance devices compared to deuterium water (D2O) measurements. HYPOTHESIS: The Biospace Body Composition Analyzers are valid tools for measuring total body water and body composition.
Primary Outcome
from BIA and from D2O
Interventions
- OTHER observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-05 |
What the finished NCT01607229 record still lists
NCT01607229 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which observation is the first listed.
NCT01607229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01607229 about?
NCT01607229 is a clinical study titled "Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution". SPECIFIC AIM: Determine the validity of the Biospace bioelectrical impedance devices compared to deuterium water (D2O) measurements. HYPOTHESIS: The Biospace Body Composition Analyzers are valid tools for measuring total body water and body composition.
What is the current status of trial NCT01607229?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01607229?
The interventions under investigation include: observation (OTHER).
Who is sponsoring clinical trial NCT01607229?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia